Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4-through 6-year-old children

PW Annunziato, EP Rothstein… - … of pediatrics & …, 1994 - jamanetwork.com
Objective: To compare the safety and immunogenicity of a three-component acellular
pertussis (DTaP) vaccine containing pertussis toxin (PT), filamentous hemagglutinin (FHA) …

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four-to six-year-old children

ME Pichichero, KM Edwards, EL Anderson… - …, 2000 - publications.aap.org
Objective. To evaluate the safety and immunogenicity of 6 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …

Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight …

HJ Schmitt, K Beutel, A Schuind, M Knuf… - The Journal of …, 1997 - Elsevier
Objectives: The primary objective was to assess the nature and incidence of adverse events
after a fourth dose of a tricomponent acellular pertussis-diphtheria-tetanus vaccine given in …

Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15-through 20-month-old infants

HH Bernstein, EP Rothstein… - …, 1994 - publications.aap.org
Objective. To compare the immunogenicity and reactogenicity of a diphtheria and tetanus
toxoids and three-component acellular pertussis vaccine (DTaP) with a diphtheria and …

Comparison of a three-component acellular pertussis vaccine with whole cell pertussis vaccine in two-month-old children

ME PICHICHERO, JL GREEN… - The Pediatric …, 1994 - journals.lww.com
An acellular pertussis vaccine (DTaP) containing pertussis toxoid, filamentous
hemagglutinin and the 69-kDa outer membrane protein (pertactin) was compared with …

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15-to 20-month-old children

ME Pichichero, MA Deloria, MB Rennels… - …, 1997 - publications.aap.org
Objective. To compare the safety and immunogenicity of 12 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria …

Comparison of 13 acellular pertussis vaccines: overview and serologic response

KM Edwards, BD Meade, MD Decker, GF Reed… - …, 1995 - publications.aap.org
Objective. To compare the immunogenicity of a licensed conventional whole-cell (WCL) and
13 diphtheria-tetanus-acellular pertussis (DTaP) vaccines that differed in source, method of …

Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age

DI BERNSTEIN, VE SMITH, GM SCHIFF… - The Pediatric …, 1993 - journals.lww.com
The safety and immunogenicity of a booster dose of a new acellular pertussis component
diphtheria-tetanus toxoids-pertussis vaccine (DTaP) were compared with whole cell …

Acellular pertussis vaccination of 2-month-old infants in the United States

ME Pichichero, AB Francis, MM Blatter… - …, 1992 - publications.aap.org
This is the first study in children from the United States that evaluates the immunogenicity of
and adverse reactions to the Connaught/Biken two-component acellular pertussis vaccine …

Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants

HJ Schmitt, A Schuind, M Knuf, K Beutel… - The Journal of …, 1996 - Elsevier
OBJECTIVES: To assess the safety and tolerability of 12 lots of SmithKline Beecham
Biologicals' diphtheria-tetanus-tricomponent acellular pertussis vaccine (DTaP) in a large …